Ray WJ, Mildvan AS, Grutzner JB (December 1977). "Phosphorus nuclear magnetic resonance studies of phosphoglucomutase and its metal ion complexes". Archives of Biochemistry and Biophysics. 184 (2): 453–463. doi:10.1016/0003-9861(77)90455-6. PMID23074.
Rhyu GI, Ray WJ, Markley JL (January 1984). "Enzyme-bound intermediates in the conversion of glucose 1-phosphate to glucose 6-phosphate by phosphoglucomutase. Phosphorus NMR studies". Biochemistry. 23 (2): 252–260. doi:10.1021/bi00297a013. PMID6230103.
Ray WJ, Puvathingal JM, Liu YW (July 1991). "Formation of substrate and transition-state analogue complexes in crystals of phosphoglucomutase after removing the crystallization salt". Biochemistry. 30 (28): 6875–6885. doi:10.1021/bi00242a011. PMID1829964.
Mineo I, Kono N, Hara N, Shimizu T, Yamada Y, Kawachi M, et al. (July 1987). "Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII". The New England Journal of Medicine. 317 (2): 75–80. doi:10.1056/NEJM198707093170203. PMID3473284.
Mineo I, Tarui S (1995). "Myogenic hyperuricemia: what can we learn from metabolic myopathies?". Muscle & Nerve. Supplement. 3: S75 –S81. doi:10.1002/mus.880181416. PMID7603532. S2CID41588282.
Ray WJ, Mildvan AS, Grutzner JB (December 1977). "Phosphorus nuclear magnetic resonance studies of phosphoglucomutase and its metal ion complexes". Archives of Biochemistry and Biophysics. 184 (2): 453–463. doi:10.1016/0003-9861(77)90455-6. PMID23074.
Rhyu GI, Ray WJ, Markley JL (January 1984). "Enzyme-bound intermediates in the conversion of glucose 1-phosphate to glucose 6-phosphate by phosphoglucomutase. Phosphorus NMR studies". Biochemistry. 23 (2): 252–260. doi:10.1021/bi00297a013. PMID6230103.
Ray WJ, Puvathingal JM, Liu YW (July 1991). "Formation of substrate and transition-state analogue complexes in crystals of phosphoglucomutase after removing the crystallization salt". Biochemistry. 30 (28): 6875–6885. doi:10.1021/bi00242a011. PMID1829964.
Mineo I, Kono N, Hara N, Shimizu T, Yamada Y, Kawachi M, et al. (July 1987). "Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII". The New England Journal of Medicine. 317 (2): 75–80. doi:10.1056/NEJM198707093170203. PMID3473284.
Mineo I, Tarui S (1995). "Myogenic hyperuricemia: what can we learn from metabolic myopathies?". Muscle & Nerve. Supplement. 3: S75 –S81. doi:10.1002/mus.880181416. PMID7603532. S2CID41588282.
Sugie H, Kobayashi J, Sugie Y, Ichimura M, Miyamoto R, Ito T, et al. (April 1988). "Infantile muscle glycogen storage disease: phosphoglucomutase deficiency with decreased muscle and serum carnitine levels". Neurology. 38 (4): 602–605. doi:10.1212/WNL.38.4.602. PMID2965317. S2CID11491932.
Mineo I, Tarui S (1995). "Myogenic hyperuricemia: what can we learn from metabolic myopathies?". Muscle & Nerve. Supplement. 3: S75 –S81. doi:10.1002/mus.880181416. PMID7603532. S2CID41588282.